Partnering is the key to our success. It plays an essential role for Nycomed Russia-CIS development. Partnerships enable us to strengthen our position in the largest markets and to perform our main mission – to bring medicines that matter to patients and healthcare providers.
Every partner, product, market and consumer is important to Nycomed. We treat in-licensed products as own and we make every effort for their promotion. In Russia and CIS Nycomed provides marketing support for the promotion and sale of products from the leading pharmaceutical manufactures. What differs us: reliability, open-mindedness, flexibility, dynamics, result-orientedness, extensive market knowledge of Russia and CIS.
Nycomed Russia-CIS has reached long-term exclusive partnership agreements with such companies as MERCK Serono, GE Healthcare, BIOGEN Idec, ALMIRALL, S.A., LEO Pharma A/S, CHIESI Farmaceutici S.p.A., GRUPO FERRER Internacional, S.A., Laboratoires GILBERT, S.A., ORPHAN EUROPE SARL, part of the Recordati Group., VIFOR Pharma Ltd, EURAND and ACTELION Pharmaceuticals Ltd.
The Russian market covers 11 time zones, it is an enormous market and it is characterized by huge cultural differences and a lack of uniformity. It is a market that is developing dynamically, and we are continually adjusting our product portfolio and organization to match the demands of the market.
Nycomed aims at long-term successful partnership.